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A B S T R A C T
Human biological samples with multiple contributors remain one of the most challenging aspects of DNA typing
within a forensic science context. With the increasing sensitivity of commercially available kits allowing de-
tection of low template DNA, complex mixtures are now a standard component of forensic DNA evidence. Over
the years, various methods and techniques have been developed to try to resolve the issue of mixed proﬁles.
However, forensic DNA analysis has relied on the same markers to generate DNA proﬁles for the past 30 years
causing considerable challenges in the deconvolution of complex mixed samples. The future of resolving com-
plicated DNA mixtures may rely on utilising markers that have been previously applied to gene typing of non-
forensic relevance. With Massively Parallel Sequencing (MPS), techniques becoming more popular and acces-
sible even epigenetic markers have become a source of interest for forensic scientists.
The aim of this review is to consider the potential of alleles from the Human Leukocyte Antigen (HLA)
complex as eﬀective forensic markers. While Massively Parallel Sequencing of HLA is routinely used in clinical
laboratories in ﬁelds such as transplantation, pharmacology or population studies, there have not been any
studies testing its suitability for forensic casework samples.
1. Issues with challenging DNA samples
Advancements in DNA recovery and processing has led to the de-
velopment of highly sensitive STR kits [1,2] combined with the in-
troduction of analysis methods designed for low template DNA samples
[3–6] has made obtaining DNA proﬁles easier, quicker and more eﬃ-
cient even from trace amounts of DNA material. However, at the same
time, those advances have introduced new issues. Analysis of low
template samples has revealed many problems with relying on STR in
human identiﬁcation since STRs are very prone to stochastic eﬀects,
particularly when low copy samples are involved. Stochastic eﬀects are
random ﬂuctuations occurring during early cycles of PCR ampliﬁcation
that manifest as variations in the results from repeated analyses of the
same sample. Ampliﬁcation of the same source material may therefore
result in diﬀerent alleles being observed at a particular locus. Two ex-
amples of the outcome of stochastic eﬀects are allelic drop-out and
allelic drop-in. When dealing with low template DNA, the sensitivity of
the analysis needs to be increased [3] by increasing the number of PCR
cycles [7,8]. However, the minute amounts of source DNA combined
with the increase of cycles will often lead to allele drop-out (failure to
amplify a single allele) or locus drop out (loss of both alleles) [3]. An
allele drop-out is particularly problematic as the follow-up analysis
gives what appears to be a complete DNA proﬁle when in fact half of
the genetic information is missing. On the other hand, allele drop-in
results in appearance of an extra allele, unrelated to the source proﬁle.
Interpretation of a single source DNA proﬁle with allelic drop-ins may
lead to a false conclusion that the tested sample is a mixture. Another
common result of stochastic eﬀects occurring during PCR ampliﬁcation
is the presence of stutter peaks in the analysed proﬁle. The mechanism
behind the generation of stutter peaks is thought to be polymerase
slippage leading to slipped strand mispairing (SSM) [9]. A stutter peak
may appear one repeat unit before the true allele (caused by a deletion
of one repeat unit) or one unit after the true allele (insertion of a repeat
unit into the new strand) [10]. The most common scenario is the ap-
pearance of a new strand which is one repeat unit shorter than the
parent strand [11]. Although there have been reports of stutter peaks
being two or more repeat units smaller or larger than the true allele
[12].
Currently there are no methods to eliminate the issues with STR
proﬁling of low template DNA source material. One of the proposed
solutions to avoid misinterpretation of DNA proﬁles is simply not to
analyse and proﬁle samples with high probability of stochastic eﬀects
[13]. This ‘stop testing’ approach however is not free of ﬂaws. First of
all, it can signiﬁcantly limit the evidence available at a crime scene,
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although the most common types of DNA evidence found at scenes of
crime are usually sources with a potentially high DNA content such as
blood [14], there are instances where the only available biological
evidence is present in the form of a low template, trace DNA.
The other major issue with STRs is diﬃculty in interpretation of the
results from mixed samples containing DNA from several contributors
in various proportions. It can be especially tricky in cases where the
major DNA contributor masks the presence of minor contributors. This
is caused by the fact that the STR primers are designed for speciﬁc loci.
Two or more contributors can have alleles from the same locus with
diﬀerent numbers of repeats. In cases with highly unbalanced mixtures,
the STR markers will not be able to diﬀerentiate between the alleles
from the same locus. The PCR-based analytical method generally allows
for the detection of a minor DNA contributor in an unbalanced mixture
only when its contribution is more than 10% of the total DNA content.
However to be able to detect all the minor alleles, the minor contributor
has to be at least 20% of the total DNA [15]. Low template DNA sam-
ples with many contributors are now part of many forensic investiga-
tions, still their interpretation remains challenging [16]. Despite var-
ious tools developed to help with deconvolution of mixed samples
[17–22], a recent report published by Butler et al. [23] showed some
worrying results. As part of interlaboratory study in 2013, the National
Institute of Standards and Technology provided the same data from the
proﬁling a DNA sample with multiple contributors to 108 laboratories
across United States and Canada. The sample was accompanied by a
mock crime scene scenario; the DNA evidence was recovered from a ski
mask found near the scene of bank robbery. Along with the evidence
proﬁling results, all the laboratories were sent proﬁles of three potential
suspects (A, B, C). Out of 108 laboratories taking part in the study, 74
(69%) determined that all three suspects contributed to the DNA mix-
ture. When in fact suspects A and B were contributors to the mixture;
suspect C however was not part of the mixed proﬁle. In a real life
scenario, such a mistake in proﬁle interpretation may result in an arrest
of an innocent bystander.
The relatively high rate of mutation of STRs adds another limitation
to their reliability in human identiﬁcation [24]. Those mutations may
cause major diﬃculties in kinship analysis, as they can lead to the
combined kinship index (CKI) or combined paternity index (CPI) not
reaching the required threshold. In consequence, additional STR mar-
kers have to be applied. This involves additional costs, workload and
time spent on the analysis, without any guarantee that the additional
markers will prove to be suﬃcient.
2. Current methods of sample deconvolution
With current methodologies, mixture deconvolution using STR
markers alone is not as reliable as would be desirable. Therefore the
investigation focus has shifted into exploring other markers as a po-
tential aid to STR in complex mixtures.
An example of such is deletion/insertion polymorphism. Deletion/
Insertion Polymorphism (DIP) is part of the human DNA length poly-
morphism group based on the insertion or deletion of one or more
nucleotides, also known as indels [25]. The indels are responsible for
approximately 16 to 25% of human DNA variation [26]. With the
majority of sequences being shorter than 100 bp [27], DIP seems like a
suitable tool for analysis of degraded DNA samples.
DIP's potential to aid forensic casework in relation to resolving the
issue of mixed samples was ﬁrst mentioned in 2011 [28]. The in-
novative method linked the deletion/insertion polymorphism with
standard short tandem repeats (DIP-STR), utilising the polymorphic
properties of both markers and therefore resulting in higher dis-
criminatory power than STR markers alone. Despite the fact that on
their own, the biallelic DIPs are associated with a low power of dis-
crimination [15]. In order for DIPs and STRs to form a marker, the two
loci cannot be independent from each other, have to be less than 500 bp
apart and close enough together to make recombination events highly
unlikely [29].
The DIP-STR markers are not only highly polymorphic and located
throughout the whole genome [15], but are also very easy to genotype
as the typing method is the same as it is for standard STR proﬁling [30].
The markers have been successfully applied to resolve extremely un-
balanced DNA mixtures with two contributors, producing a high re-
solution proﬁle from a donor with only 0.1% of contribution to the
analysed DNA mixture [28]. Targeting DNA of the minor contributor
for the alleles missing in the major donor’s proﬁle is possible due to
variations in DIP sequence that allow for designing two allele speciﬁc
primers, one for the deletion (S-DIP) and one for the insertion (L-DIP
primer) [28]. To test the utility and feasibility of the marker, Castella
et al. [15] applied the system to an unbalanced DNA mixture from a
homicide case. The collected evidence pointed to three potential sus-
pects; a man and his two sons, each from a diﬀerent mother. The tested
samples included a biological stain recovered from the victim’s body
and reference DNA samples from the three suspects. The initial analysis
was done with the standard autosomal kit and the generated results
pointed out to just one female STR proﬁle with no traces of a minor
male DNA contributor. Only after applying Y chromosome speciﬁc
markers, the researchers were able to obtain one Y chromosome proﬁle.
However with all 3 suspects being part of the same paternal line, their Y
chromosomes were practically identical hence the proﬁling results had
no discriminatory power to distinguish between the individuals. Only
after DIP-STR typing, Castella et al. detected a haplotype matching only
one of the three suspects.
A few sets of the DIP-STR markers have been developed and tested
for a variety of samples including ‘touch’ DNA [30,31]. These DIP-STRs
markers are suitable for typing from degraded and cell-free DNA and
produce fewer PCR artefacts, including stutter peaks. Thanks to the
high degree of polymorphism for each DIP, the combined markers have
greater chances of identifying the alleles unique to the minor con-
tributor in an unbalanced mixture [30] and consequently help to de-
termine the number of contributors in a mixed sample. The application
of DIP-STR in real forensic cases shows clear advantage of the combined
markers over standard STR and Y chromosome typing when it comes to
unbalanced DNA mixtures. Where STR markers failed to detect any
contribution of a minor donor in the mixture and Y-STR marker was not
able to diﬀerentiate between the related male suspects, the DIP-STR
marker set has emerged as a promising tool for challenging samples.
With the ability to utilise already established methods and analytical
techniques, the combination of DIP and STR markers can be easily
implemented in forensic laboratories without any extra costs involved.
Other potentially useful markers can be found in single nucleotide
polymorphism (SNP) substitutions. A SNP is deﬁned as a single nu-
cleotide variation between individuals. Such a variation occurs at a
speciﬁc point in the DNA sequence. These polymorphisms are thought
to be responsible for 90% of all of human sequence variants [32]. The
nucleotide variants are very common in the human genome, occurring
on average once in every 100 to 300 nucleotides [33]. Due to their
abundance, SNPs are widely used in disease related gene mapping [34].
There are several characteristics of SNPs that make them useful
markers for forensic analysis. First of all, when ampliﬁed, their PCR
products are less than 100 base pairs in length, which means that they
are the perfect size markers for analysing highly degraded DNA sam-
ples. For comparison, the standard STR ampliﬁcations generate am-
plicons that are about 300–400 bp long [35]. Another advantage of
SNPs over STR markers is their low mutation rate, making them valu-
able markers for paternity tests as well as other kinship analyses [36].
Unlike STR typing, proﬁling of SNPs does not produce any stutter peaks
[37] thus allowing for easier result interpretation. Additionally, some of
the tetra-allelic SNPs are close in their discrimination level to simple
STRs (CSF1PO and TPOX) and can be easily ampliﬁed from much
shorter sequences [38].
Unfortunately due to their binary nature, the majority of SNPs are
unable to detect more than one contributor in a mixed sample [39].
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However, as shown by Westen et al. in their study from 2009, applying
the tri-allelic SNPs to a 2 donor sample can reveal the presence of a
second donor with a ratio up to 1:8 [40]. The authors suggest that the
second donor presence is detected by the appearance of a third allele on
one locus, unexpected peak height ratios and/or peaks above the de-
tection threshold. Still, their experiment was conducted in a controlled
lab environment with a known number of contributors. When analysing
a crime scene sample with an unknown number of donors, it would not
be possible to determine the contribution of more than two individuals.
Similar to the tri-allelic SNPs, the tetra-allelic SNPs system only allows
for the detection of two-contributor mixtures [38].
Fortunately, as in case of DIP markers, the forensic potential of SNPs
can be increased by linking them with STRs. In 2013 L. Wang et al.
introduced a new method for simultaneous analysis of short tandem
repeats together with single nucleotides called SNP-STRs [41]. The
combined markers along with allele speciﬁc primers allow for detection
of a minor contributor in a mixed sample and have a higher sensitivity
than the standard STR markers alone. Additionally, SNP-STR typing
does not require any additional genotyping techniques and can be
analysed using methods routine for STR proﬁling. In their follow-up
study, L. Wang et al. suggested that typing of SNP-STR is more eﬃcient
than applying the DIP-STR combination when dealing with unbalanced
mixtures [42].
Furthermore, SNP based markers known microhaplotypes have
been recently emerging as potential tool in mixture interpretation
[43,44]. Micorohalpotypes (microhaps) consist of two or more SNPs
located within less than 200 base pairs from each other [45]. Those
closely linked SNPs can have multiple allelic variations, however due to
the short distance between SNPs, the chances of recombination are very
low [46]. Heterozygosity of microhaps can be inﬂuenced by various
factors such as rare cross over events, accumulation of allelic variants at
diﬀerent locations within the region of interest throughout time and
random genetic selections and drifts [46]. Similarly to SNPs, microhaps
contain fewer alleles in comparison to STR. Therefore, in order to reach
comparable level of information, a high number of microhap panels are
required. Such panels are being developed and tested against un-
balanced mixtures [43,44] with promising results when combined with
Massively Parallel Sequencing (MPS), a technique capable of sequen-
cing whole human genome. Additionally, microhaplotypes have proven
to be the highest performing markers in ancestry analysis when com-
pared against SNPs and indels [47]. Their application and beneﬁts to
forensic science has recently been extensively reviewed in other pub-
lications [48,49] and therefore will not be considered further in this
review.
3. Human leukocyte antigen
The Human Leukocyte Antigen (HLA) system known also as the
Human Major Histocompatibility Complex (MHC) consists of more than
20,000 identiﬁed alleles [50] located on chromosome 6p21. This
complex has been found to be the most polymorphic gene system dis-
covered in the human genome [51]. Apart from being highly poly-
morphic, the system is also characterised by a high linkage dis-
equilibrium and high density of genes [52]. The role of the HLA system
is to help the body’s immune system distinguish between its own pro-
teins and the foreign proteins made by viruses and bacteria.
The HLA complex can be categorised in three main groups; Class I,
Class II and Class III. Class I consists of the three main subgroups: HLA-
A, HLA-B and HLA-C with 4200, 5091 and 3854 identiﬁed alleles per
group, respectively [50]. The other three subgroups, HLA-E, HLA-F,
HLA-G contain less than 100 described alleles each [50]. The proteins
produced by the genes from Class I are transmembrane glycoproteins
(antigens) located on the surface of every nucleated cell. These glyco-
proteins bind to the peptides that are derived from the protein break-
down system of the cell. If the immune system recognises those peptides
as foreign (i.e., sourced from a bacteria or virus), it triggers the immune
response and the infected cells are targeted for destruction. Out of all
three classes, Class I is the most polymorphic [53] with HLA-B genes
showing the highest polymorphism [52], consisting of over 5000
identiﬁed alleles [50]. The majority of the HLA alleles identiﬁed so far
belong to Class I (13,324) [50,54]. Class II molecules consist of DP, DQ,
DR, DM and DO gene groups. These gene groups create the following
allele groups: HLA-DPA1 & HLA-DPB1, HLA-DPA2 & HLA-DPB2, HLA-
DQA1 & HLA-DQB1, HLA-DMA & HLA-DMB, HLA-DOA &HLA-DOB,
HLA-DRA, and HLA-DRB1 to DRB9. The majority of alleles in class II
belong to HLA-DRB1 (2165 alleles) and DQB1 (1196 alleles) [50]. The
Class II proteins are expressed on B-lymphocytes and monocytes where
their role is similar to that of Class I. The Class III group does not encode
any HLA molecules [55] but it contains many genes involved in the
inﬂammatory responses [56].
Genes of the HLA system are closely linked together and as a result,
the whole complex is inherited as a haplotype. However, there are
possibilities for random recombination within the haplotype. In the
majority of the cases, the distance between genes on the chromosome
determines the chances of such an event. As documented by Martin
et al. [57,58] recombination rates within HLA class II region (between
DRB1 and DPBI/DPB2) were 0.74% and 0.94% for class III region
(between HLA-B and DRB1 loci). Surprisingly the recombination rate
for class I, deﬁned by the authors as the region extending from HLA-A
to HLA-B (1.4 Mb), was only 0.21%. The determined value was much
lower than expected considering the distance between both genes.
Based on the observed results, the authors suggest that some haplotypes
may be more prone to recombination than others and that the reported
recombination rates indicate a non-random pattern of recombination.
Since their study, instances where recombination within HLA haplotype
has occurred within the same family have been documented [59,60].
Generally, the inheritance is ruled by Mendelian law, with one HLA
haplotype coming from each parent. Two children from the same par-
ents have 50% chance of sharing one haplotype (haploidentical), 25%
chance of having no haplotypes in common and 25% chance of being
genotypically identical [55]. In case of unrelated individuals, the pos-
sibilities of random combinations of HLA antigens on a haplotype are
immense.
Variation and polymorphism of the HLA complex has played a
crucial role in studying population migration [61] as well as being used
to establish ethnic genetic database and linkage analysis [62]. The HLA
proteins are responsible for mediating immune responses and therefore
also play a very important role in organ transplantation [53,54] as they
are unique for every unrelated individual [63]. HLA testing, also known
as tissue typing, is primarily used to determine the compatibility be-
tween an organ donor and organ recipient by identifying the antigens
on their blood cells [53].
Historically, HLA typing was done by serological testing, where
antibodies were used to distinguish between diﬀerent variants of anti-
gens. Each antigen had its own speciﬁc antibody and the HLA ser-
otyping allowed determination of the degree of match between the
donor and recipient serotypes. The higher the number of the identical
antigens between the potential donor and recipient, the more likely it is
that the transplant will be successful. This method however is limited
by the number of antibodies available for the speciﬁc HLA antigens.
Standard HLA serotyping has recently been replaced by superior
molecular testing techniques, allowing for more alleles to be identiﬁed.
HLA typing is currently done by a combination of PCR ampliﬁcation
and the analysis of the genomic DNA [54]. There are three main types
of DNA-based typing [64]; low resolution, characterised by being able
to deﬁne a gene subtype by allocating ﬁrst two digits for the gene alleles
(Fig. 1.), high resolution which can be deﬁned as a set of alleles coding
for the same protein but with diﬀerent DNA sequences, and ﬁnally the
allelic resolution, sensitive enough to determine single alleles in the
coding sequence. The level of required resolution may depend on the
type of transplant.
The current typing technologies include sequence-speciﬁc
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oligonucleotide probes, sequence-based typing (SBT), PCR restriction
fragment length polymorphism (PCR-RFLP), and sequence speciﬁc
primer ampliﬁcation and micro-array techniques [62]. Of these, the
micro-array techniques have proven to be the most eﬃcient for de-
tecting all the allele variants [62]. The micro-array method has made it
possible to analyse over 1000 HLA alleles on a single microarray slide
[62] while using a small sample volume [65]. As of late, HLA alleles are
being sequenced with high throughput MPS [61,66–68]
4. Application of the human leukocyte antigen complex in the
ﬁeld of forensic science
The potential of the HLA system for forensic DNA typing has not yet
been fully evaluated as the majority of the conducted studies focus on
medical applications such as tissue transplant and links between HLA
alleles and disease states [69]. Based on previous applications it is safe
to assume that the most important characteristic of the HLA complex,
which could be utilised in forensic casework, is the high genetic poly-
morphism within the antigen peptide-binding region. Exons 2 and 3
within HLA class I and exon 2 within class II are the sequences that
encode the peptide antigen binding site of the HLA proteins [50]. Due
to the high degree of polymorphism, these sections are sequenced in
majority of non-forensic related applications [70], and are also the
main regions of interest in forensic studies.
Of the studies focusing on the potential utilisation of HLA sequences
in forensic science the majority [62,71–78] predate the development of
MPS technology. Interestingly, the ﬁrst ever PCR-based DNA kit was
developed for detecting a variation at class II HLA gene DQA1 and re-
leased in 1990 [79]. The kit was successfully evaluated by forensic
laboratories for its suitability for common forensic samples [77,80].
The DQA1 based PCR tested positively against a variety of forensic
specimens such as blood, hair and tissue [74], bloodstains exposed to
various contaminants [76] and semen-containing materials [78]. HLA-
DQA1 typing was also successful when dealing with mixed ﬂuid sam-
ples (sperm and vaginal cells) from rape cases [81] and allowed for
positive identiﬁcation of severely burnt cadavers [75]. An example of a
more recent study is an investigation conducted in 2006 by researchers
from Shanghai [62]. The aim of their research was to evaluate the
forensic potential of HLA-DRB1, the subgroup within Class II with the
highest number of alleles (2146) [50]. The process of HLA based DNA
typing is similar to standard DNA typing, in that the extraction of DNA
and ampliﬁcation by PCR is identical to the corresponding steps in STR
based analysis, with the exception of the primer sets used. The follow-
up micro-array hybridization allowed for a rapid and large-scale ana-
lysis. Even though the HLA systems are present in various animal
species, the HLA typing proved to be human speciﬁc. None of the DNA
samples extracted from the animal tissue (blood and muscle) produced
PCR amplicons capable of hybridisation to the array. Sensitivity of the
system was tested by using diﬀerent DNA dilutions, ranging from
200 ng to as low as 10 ng. In their 'Evaluation for use in forensic identi-
ﬁcation' section, the authors claim that the template DNA concentration
of 10–15 ng was enough for the HLA-DBR1 typing. In the abstract
however, they state that 15 ng is the minimal amount required for a
successful genotyping. This suggests that any DNA concentration below
15 ng would fail to produce satisfactory results. The analysed dilutions
reported are suitable for standard DNA typing but further sensitivity
tests would be required to determine whether the method could be
suitable for detection of low template DNA, ranging from 10 pg to as
low as 0.25 pg. The method was also not applied to any samples with
more than one contributor, making it impossible to predict whether it
could be suitable for complex DNA mixture analysis. Nonetheless, the
method proved suitable for typing from variety of materials. Apart from
human blood used as the main source of DNA in the project, the other
analysed sources included semen samples, cigarette butts and hair
roots. All of which produced good HLA-DBR1 typing results.
The outcome of this study allowed the deﬁnition of a few further
characteristics that could aid forensic DNA typing. First of all, the dis-
tribution of alleles makes the HLA-DBR1 system a useful tool in DNA
typing. The analysed population data suggested that allele frequency
did not seem to be in Hardy–Weinberg equilibrium. Signiﬁcant diﬀer-
ences were observed not only between people of diﬀerent races but also
within diﬀerent ethnic groups of people belonging to the same race.
Secondly, all the alleles speciﬁc to the HLA-DBR1 group can be detected
using only one single PCR ampliﬁcation. This is possible due to the fact
that all the array oligonucleotide probes are between the two target
primers. This feature makes it a valuable marker in cases involving
disaster victim identiﬁcation, when the only source of available DNA
can be found in the form of highly degraded samples. Furthermore, due
to its polymorphism and large-scale output with micro-array testing,
HLA typing can be used in conjunction with standard STR typing,
giving it a higher discriminatory power.
In another study from 2006 the sequence speciﬁc primer and probe
typing of HLA was validated in forensic testing [71]. The study used a
commercially available PCR-SPP (sequence speciﬁc primer and probe)
HLA typing kit, capable of typing Class I and II HLA alleles from small
amounts of DNA (10 ng) at low resolution by allocating the ﬁrst two
digits in the allele nomenclature system described above. Even though
the highly polymorphic HLA loci can be very useful in forensic science,
it has proven diﬃcult to simultaneously proﬁle alleles from Class I and
Class II when dealing with low template DNA samples such as formalin-
Fig. 1. New HLA nomenclature system adopted in 2010 (S.G.E. Marsh, HLA Informatics Group, http://hla.alleles.org/nomenclature/naming.html).
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ﬁxed paraﬃn-embedded (FFPE) tissues, nail, hair pieces and other trace
DNA evidence encountered during a forensic examination [71]. The
source material used in the study consisted of DNA samples obtained
from 1 µl of blood deposited on a piece of cotton cloth and stored from
1 week to 3 months, buccal cells and samples from real forensic cases in
the form of blood stains that had been stored at room temperature for
18 years.
The results showed that full HLA typing was possible for DNA ob-
tained from blood covered cloth at each stage of decomposition. The
HLA-SPP typing system proved to be very sensitive and did not require
isolation of the DNA prior to the PCR ampliﬁcation. This is signiﬁcant
since by reducing the number of steps involved in DNA typing, the
chances of sample contamination with any carryover reagent during the
process of extraction are signiﬁcantly reduced.
In a study conducted in 2003 [72], HLA typing with the PCR-SSP
method was used to identify bodies using DNA obtained from aortic
tissue. The aortas were collected from eight bodies, one of them was
burnt, one was mummiﬁed and the remaining six were found in water.
The attempt to identify the bodies was made by typing alleles from
HLA-A, HLA-B, HLA-DR and HLA-DQ. The DNA was isolated from 1 mg
of ﬁxed tissue or from 10 to 20 mg of aortic tissue and the yield of DNA
obtained ranged from 0.04 to 3.84 μg. The amounts were suﬃcient to
type for multiple HLA loci and the obtained results were consistent with
the alleles typed from the bones of the corresponding bodies. Ad-
ditionally, extracting DNA from the aortic tissue proved to be easier
than extracting DNA from teeth and bones, establishing the aortic tissue
as a valuable forensic material. Unlike the two previous cases, this
study attempted HLA typing from amounts of DNA much lower than
10 ng. The alleles from HLA-DR locus were successfully typed for every
single case, even for the DNA content as low as 0.04 μg and 0.06 μg.
5. Potential of massively parallel sequencing in forensic analysis
of the human leukocyte antigen complex
Before the introduction of MPS, high-resolution HLA typing was
challenging due to the large number of alleles and patterns of poly-
morphism [82]. The standard SBT method was unable to determine
phasing of sequences, often requiring application of complimentary
methods [83]. Phasing of HLA sequences can be deﬁned as determining
haplotypes from alleles and mutations. Unlike the previous methods,
MPS allows for thorough sequencing at a molecular level. MPS tech-
niques are capable of detecting a single nucleotide variation. This fea-
ture is particularly important for sequencing of HLA genes, due to their
high degree of polymorphism which is often dependent on point mu-
tations.
As previously mentioned, everyone inherits a maternal and paternal
set of the HLA alleles. Those alleles are co-dominantly expressed in a
cell; therefore, it may be diﬃcult using serotyping or low resolution
allele determination to interpret the HLA typing data from both alleles
together as genotypes with two separate alleles. The results that are
consistent with more than one genotype are referred to as ‘ambiguous
data’ [84]. This ambiguity is a consequence of the complexity of the
HLA system and is considered to be a major challenge when typing and
interpreting the HLA data using the standard sequence-based methods
such as Sanger sequencing [84]. Resolving those issues would often
prove complicated, expensive and time consuming [82].With the ad-
dition of MPS, typing of HLA without ambiguities became a possibility
[85,86] since MPS enables detecting polymorphisms in unknown alleles
alongside the already known alleles, novel alleles are still being dis-
covered [83].
So far it has been proven that MPS allows for a successful typing of
DNA with concentrations of 2 ng/µL [87] and since there is no need to
test very low concentrations of DNA for clinical samples, further tests to
determine suitability of the HLA typing for low template DNA are re-
quired. An important point to take into consideration when running a
PCR plate is making sure that the samples with similar typing are
positioned distant from each other. Increasing the distance between the
potentially HLA-matched samples will reduce the chances of con-
tamination [87]. However, it is only important in the ﬁrst step of library
preparation. The follow up PCR reaction involves tagging each sample
with a unique molecular barcode, allowing the sequencer and software
system to separate and isolate the data generated from each sample
[88].
There are certainly some disadvantages of the MPS method. First
and foremost, there are high costs involved in implementing MPS
technology in a crime laboratory. The main costs involve an MPS in-
strument and kits that are much more expensive than the standard STR
proﬁling kits. The average price for a reference sample is about £45
while a casework sample will cost around £65 however these costs are
continuing to fall as general MPS use is increasing. In comparison the
average price for standard STR analysis is about £14 to £19 [89].
Secondly, there are potentially longer turnaround times. With massive
parallel sequencing, it can take 24 or more hours to obtain the relevant
proﬁling information. In comparison, getting 20 CODIS markers can be
achieved in 6 to 8 h [90]. Furthermore, an MPS analysis generates a
vast amount of data. Each run produces approximately 18 gigabytes of
data [87]. This in turn creates a need for specialist software to enable
extraction of the desired information. The most cost-eﬀective approach
to MPS analysis could be triage of samples. The simple, straightforward
samples with plenty of source material could still be analysed with
standard STR techniques, while the complex, mixture and low con-
centration samples would be sequenced with high-throughput methods.
The potential disadvantages involved in the MPS technology should
not stop researchers from exploring and utilising its full potential. No
technique is free of faults and even if in the long run MPS proves to be
unsuitable for routine use, there are always the standard methods to fall
back on. However, as many recent publications conﬁrm; massive par-
allel sequencing has certainly demonstrated its value as an emerging
technology in many ﬁelds of science. Markers such as STRs, mtDNA and
YSTR have already signiﬁcantly increased their forensic value due to
MPS [91]. While MPS of HLA is being routinely utilised in clinical la-
boratories in ﬁelds such as transplantation [92], pharmacology [93] or
population studies [61], there have not been any studies testing its
suitability for typical forensic samples. However a recent study by Wu
et al. [66] showed promising results of applying HLA-based typing to
kinship analysis. In the study HLA haplotypes of 24 individuals from the
same family spanning six generations were determined. The HLA genes
used in the study were part of a standard Illumina TruSight HLA typing
kit (Illumina, Inc., San Diego, CA) and included HLA-A, -B, -C, -DRB1,
-DRB3, -DRB4, -DRB5, -DPA1, -DPB1, -DQA1 and -DQB1. Alongside
HLA typing, the samples provided by the family were analysed with 23
STR loci, 20 of which were CODIS core loci [94] and a sex marker. The
resolution of HLA typing was conducted at ﬁeld 4 level (see nomen-
clature above) which resulted in a total of 88 unique alleles in 24 tested
samples 8 of which were not previously recorded in the IMGT/HLA
database [50]. This is not a rare occurrence during an MPS analysis, as
previously stated the technology allows for detection of novel poly-
morphisms as well as known at the same time [83]. The immense
polymorphism of the HLA complex was further conﬁrmed by a total of
21 diﬀerent haplotypes found in 24 closely related individuals 3 of
which were created due to random recombination, as described in the
ﬁrst section of this review and detailed by Martin et al. [57,58]. This
generation of haplotypes by recombination events adds additional
discriminatory power to kinship analysis and human identiﬁcation. STR
analysis revealed only two mutations, which required additional con-
ﬁrmation by MPS. Furthermore, the calculated likelihood ratio (LR)
showed higher overall performance of HLA alleles when compared with
STR markers in relationship testing. This novel study shows how HLA
alleles may aid in complicated kinship and paternity analyses. Wu et al.
[66] have provided an important starting point for reintroducing HLA
genes back into forensic analysis. Paternity and kinship testing however
are not the most challenging aspect of forensic identiﬁcation, therefore
A. Kuﬀel, et al. Science & Justice 60 (2020) 1–8
5
in order to fully introduce HLA as an aid to diﬃcult forensic samples,
additional testing requirements must be taken into consideration. First
of all, the already existing HLA testing kits are not suitable for analysis
of a typical crime scene sample with low DNA concentration. For in-
stance, the TruSight HLA protocol recommends a DNA input of 400 ng
and because the kit relies on the long-range PCR, the DNA should be
intact with at least 50% of input DNA being greater than 10 kb. While
such requirements can be easily fulﬁlled in clinical settings, they are not
applicable to the majority of crime scene samples. In comparison, the
minimum requirement for most common STR proﬁling systems is
0.1–0.5 ng [95]. The forensic application of HLA will certainly require
implementation of a new approach with primers targeting shorter se-
quences. Instead of targeting the majority or even the whole gene as it is
currently being done for clinical kits, it would be preferable to design
primers targeting only Exons 2 and 3 which as mentioned before are the
regions of highest polymorphism. The PCR products produced from
these exons would range from 250 to 450 bp depending on the HLA
allele and class which is an ideal size for creating MPS sequencing li-
braries without any need to further size select or process the PCR
product. The only drawback of shorter target sequences would be the
partially reduced chances of discovering novel HLA alleles. As with any
other marker, a low amount of starting material can cause issues with
analysis. However, unlike STRs, MPS of HLA would not be susceptible
to stutter and would not as prone to stochastic eﬀects since the read
depth of the sequence data would clearly indicate any problems. The
issues of low template or highly degraded DNA sample could still result
in a lower level of resolution due to allele dropout, giving the se-
quenced alleles a lower power of discrimination.
The use of HLA to resolve forensic cases may seem questionable due
to the coding nature of the markers. Wu et al. [66] comments on the
potential of revealing external visible characteristics due to correlation
of some HLA alleles with diseases as an aid to criminal investigation
[66]. It is hard to imagine that this feature will be applied to forensic
investigation in the near future due to the ethical considerations. One of
the reasons why STRs are suitable identiﬁcation markers is their loca-
tion in the non-coding part of the human genome and as such are not
capable of revealing any sensitive data about an individual. In view of
the ethical considerations, the use of DNA for forensic purposes in some
countries is currently restricted by law to neutral, non-coding markers
only. This legislation however does not appear to be a barrier to the
development of markers located in the coding part of the genome. An
example of such are Forensic DNA Phenotyping (FDP) markers, based
by default on non-neutral markers. Additionally, FDP markers include
SNPs, many of which are located in coding parts of DNA such as SNPs
associated with eye colour which are located within HERC2 gene group
[96]. In fact, there is a whole European Consortium. VISAGE (Visible
Attributes through Genomics) dedicated to development of new tools
for FDP. Taking all of this into consideration, investigating HLA as
potential forensic markers should not be viewed as controversial so long
as the markers are used as a reference or comparison tool instead of
being used to report any unsolicited ﬁndings, just as in the case of any
other identiﬁcation marker located in the coding part of the genome.
Undoubtedly, introduction of any novel techniques and markers that
may rely on analysis of the coding part of human genome will require a
new set of standards governing the analysis, interpretation and use of
the forensically relevant data.
6. Conclusions
Despite their limitations, STRs remain the most reliable and wide-
spread markers used in forensic identiﬁcation. Nonetheless, in cases
where the conventional techniques fail to produce satisfactory results,
there is a demand for alternative or supplementary markers to aid the
analysis. There are already a notable number of markers that have been
studied and applied alongside STRs, yet none of them has been studied
as thoroughly nor have they acquired a status similar to common short
tandem repeats. However, with the recent development of sequencing
techniques, the focus should be shifting to the application of alternative
and often more discriminative and polymorphic markers. To date, the
scientiﬁc literature does not mention application of MPS technology in
HLA typing with regard to forensic casework. All previous studies
testing HLA alleles in forensic science were conducted before massive
parallel sequencing became available which has limited the investiga-
tion of the full potential of the HLA markers in a forensic context. Based
on the literature published until now, there is undoubtedly a gap in
forensic research. Taking into account all of the past and successful
applications of both HLA and MPS in forensic science, it is safe to as-
sume, that when combined, they could create a very powerful method
for future implementations in forensic analysis. At the same time, in-
troduction of HLA alleles into the ﬁeld of forensic identiﬁcation should
not be seen as a replacement but rather as an aid to already existing and
widely used markers. With such high polymorphism and discriminatory
power, addition of even a single HLA marker to any standard STR-based
analysis can signiﬁcantly increase chances of positive identiﬁcation
Novelty statement
The alleles from human leukocyte antigen complex have a great
potential to aid human identiﬁcation in challenging forensic cases. With
over 20,000 identiﬁed alleles, their polymorphism makes them unique
and powerful markers that have a chance to revolutionise deconvolu-
tion of DNA samples with multiple contributors. While massively par-
allel sequencing is routinely applied to improve discriminatory power
of standard and commonly used markers, not enough research is being
dedicated to investigation of novel markers. The purpose of this review
is to consider re-introducing HLA markers to the world of forensic
science. We believe that with the power of high-throughput techniques,
those markers have capability to become a valuable tool in DNA ana-
lysis and should be evaluated in forensic context.
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